openPR Logo
Press release

Oropharyngeal Cancer (Oncology) pipeline Forecast Report, H1, 2017 – Pharmaceutical Pipeline Guide [MRH]

05-31-2017 04:02 PM CET | Health & Medicine

Press release from: Market Research Provider [MRH]

Market Research Hub

Market Research Hub

Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Oropharyngeal Cancer - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Oropharyngeal Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1070436

Oropharyngeal cancer is a disease which malignant cells form in the tissue of oropharynx. Oropharynx is a middle part of the throat which includes the base of the tongue, the tonsils, the soft palate, and the walls of the pharynx. Oropharyngeal cancers can be divided into two types, HPV-positive, which are related to human papillomavirus infection, and HPV-negative cancers, which are usually linked to alcohol or tobacco use.

The Oropharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Oropharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 1, 4, 6 and 4 respectively. Similarly, the Universities portfolio in Phase I stages comprises 1 molecules, respectively.

Oropharyngeal Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope:

- The pipeline guide provides a snapshot of the global therapeutic landscape of Oropharyngeal Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Oropharyngeal Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Oropharyngeal Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Oropharyngeal Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Oropharyngeal Cancer (Oncology)

Browse Full Report with TOC @ http://www.marketresearchhub.com/report/head-and-neck-cancer-pipeline-review-h1-2017-report.html

Reasons to Buy:

The Oropharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Oropharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 1, 4, 6 and 4 respectively. Similarly, the Universities portfolio in Phase I stages comprises 1 molecules, respectively.

Oropharyngeal Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Table of Contents:
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Oropharyngeal Cancer - Overview
Oropharyngeal Cancer - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Oropharyngeal Cancer - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Oropharyngeal Cancer - Companies Involved in Therapeutics Development
Advaxis Inc
AstraZeneca Plc
Cell Medica Ltd
Celldex Therapeutics Inc

About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Follow Us on:
Twitter: https://twitter.com/MktResearchHub/
LinkedIn: https://www.linkedin.com/company/market-research-hub/
Facebook: https://www.facebook.com/MarketResearchHub/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oropharyngeal Cancer (Oncology) pipeline Forecast Report, H1, 2017 – Pharmaceutical Pipeline Guide [MRH] here

News-ID: 558373 • Views: 289

More Releases from Market Research Provider [MRH]

Global Talc Market Insights & Future Trends Analyzed till 2022
With the rise in the need for personal care items, the global demand for talc has also surged. To study the various applications as well as market status for this item, Market Research Hub (MRH) has added a fresh report to its wide repository. This research study is titled “Global Talc Market Research Report 2017”, which covers information about the production, consumption, revenue and market share concerned with the global
American Rubber Tyre Market Situation, Trends, Growth, Future Outlook during the …
A new market report with a title “American Rubber Tyre Market Research Report 2017” has been recently added to the vast online database of Market Research Hub (MRH). This report is an in-depth and professional analysis of the current as well as future scenario of the American rubber tyre market. This industry report package offers the most up-to-date market data on the actual market situation, trends, and future outlook for
African Rubber Tyre Market Situation, Trends, Growth, Future Outlook during the …
A new market report with a title “African Rubber Tyre Market Research Report 2017” has been recently added to the vast online database of Market Research Hub (MRH). This report is an in-depth and professional analysis of the current as well as future scenario of the Africa rubber tyre market. This industry report package offers the most up-to-date market data on the actual market situation, trends, and future outlook for
Asia Razor and Razor Blade Markets Growth, Size, Trends, and Forecasts till 2021
To understand the razor market status for Asia, a new report has been added by Market Research Hub (MRH) to its wide collection of research reports. The study is titled “Asia Razor and Razor Blade Markets Forecast Report 2017”, which talks about the product overview, growth rate as well as scope for the razor and razor market. This industry report package offers the most up-to-date market data on the actual

All 5 Releases


More Releases for Oropharyngeal

Global Oropharyngeal Cancer Diagnosis and Therapeutics Market to experience sign …
A report was recently published by Orion Market Research (OMR) on the global oropharyngeal cancer diagnosis and therapeutics market. According to OMR analysis, the global oropharyngeal cancer diagnosis and therapeutics market is estimated to grow with a high CAGR during the forecast period (2018-2023). Rising prevalence of oropharyngeal cancer has been the major factor driving the market growth. Additionally, increasing geriatric population and rising oropharyngeal cancer associated with them is
Oropharyngeal Global Cancer Market Research Report 2025
Oropharyngeal Cancer Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/oropharyngeal-cancer-market/80991 The report firstly introduced the Oropharyngeal Cancer basics: definitions, classifications, applications and
Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Research and Forec …
Global oropharyngeal cancer diagnosis and therapeutics market size, share, market trends, research and analysis report by diagnosis (endoscopy, biopsy, MRI, CT scan, PET-CT scan) by treatment (surgery, chemotherapy, radiation therapy, targeted therapy) forecast 2018-2023 Global oropharyngeal cancer diagnosis and therapeutics market is expected to grow at a noteworthy growth during the forecast period 2018-2023. The market is augmenting due to rising prevalence of oropharyngeal cancer, growing unhealthy lifestyle of people and
Global Oropharyngeal Cancer Diagnosis and Therapeutics Market 2018 Share, Trend, …
Global Oropharyngeal Cancer Diagnosis and Therapeutics Industry New Study On “2018-2023 Oropharyngeal Cancer Diagnosis and Therapeutics Market Global Key Player, Demand, Growth, Opportunities And Analysis Forecast” Added To Wise Guy Reports Database Oropharyngeal cancer is a malignant tumour that starts in the cells of the oropharynx. Rising prevalence of oropharyngeal cancer has been the major factor driving the market growth. More than 400,000 incidences of oropharyngeal cancer are reported every year globally.
Oropharyngeal Cancer Therapeutics Market – Growth, Trends , Share Assessments …
The global oropharyngeal cancer therapeutics market is expected to have significant growth since the pipeline for oropharyngeal cancer is growing rapidly. Also, there are no specific drugs available for the treatment of oropharyngeal cancer providing increased opportunities for the major key players. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/oropharyngeal-cancer-therapeutics-market Oral cavity tumor or oral tumor, is tumor that begins in the mouth (also known as the oral cavity). Oropharyngeal malignancy begins in
ISA Pharmaceuticals' ISA101 Studied in Phase II Oropharyngeal Cancer Combination …
Leiden, The Netherlands, April 26, 2018 – ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company focusing on rationally designed immunotherapeutics against cancer and persistent viral infections, today announced the start of a Phase II combination trial of its lead compound ISA101b and Pfizer´s 4-1BB agonist Utomilumab, which will be sponsored and conducted by The University of Texas MD Anderson Cancer Center (Houston, TX). The goal of the open-label Phase II study in